![JPM | Free Full-Text | Myopia Control with Low-Dose Atropine in European Children: Six-Month Results from a Randomized, Double-Masked, Placebo-Controlled, Multicenter Study JPM | Free Full-Text | Myopia Control with Low-Dose Atropine in European Children: Six-Month Results from a Randomized, Double-Masked, Placebo-Controlled, Multicenter Study](https://www.mdpi.com/jpm/jpm-13-00325/article_deploy/html/images/jpm-13-00325-g002.png)
JPM | Free Full-Text | Myopia Control with Low-Dose Atropine in European Children: Six-Month Results from a Randomized, Double-Masked, Placebo-Controlled, Multicenter Study
Myopia Control with Low-Dose Atropine in European Children: Six-Month Results from a Randomized, Double-Masked, Placebo-Controll
Myopia Control with Low-Dose Atropine in European Children: Six-Month Results from a Randomized, Double-Masked, Placebo-Controll
![SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 1346: Spm., om de 50 mest anvendte lægemidler på rekommandationslisterne, til sundheds- og ældreministeren SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 1346: Spm., om de 50 mest anvendte lægemidler på rekommandationslisterne, til sundheds- og ældreministeren](https://www.ft.dk/pimage/TingDok_Archive/2020_09/2253143/2253143_0001.png)
SUU, Alm.del - 2019-20 - Endeligt svar på spørgsmål 1346: Spm., om de 50 mest anvendte lægemidler på rekommandationslisterne, til sundheds- og ældreministeren
![PDF) Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety PDF) Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety](https://www.researchgate.net/profile/Niklas-Cyril-Hansen/publication/375083933/figure/fig3/AS:11431281202101373@1698723127949/Estimated-mean-change-in-Spherical-Equivalent-Refraction-pr-visit-divided-by_Q320.jpg)
PDF) Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety
![PDF) Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety PDF) Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety](https://i1.rgstatic.net/publication/375083933_Safety_and_efficacy_of_001_and_01_low-dose_atropine_eye_drop_regimens_for_reduction_of_myopia_progression_in_Danish_children_a_randomized_clinical_trial_examining_one-year_effect_and_safety/links/65407537f7d021785f22570d/largepreview.png)
PDF) Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety
![Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety | BMC Ophthalmology Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety | BMC Ophthalmology](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12886-023-03177-9/MediaObjects/12886_2023_3177_Fig3_HTML.png)
Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety | BMC Ophthalmology
![Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety | BMC Ophthalmology Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety | BMC Ophthalmology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12886-023-03177-9/MediaObjects/12886_2023_3177_Fig1_HTML.png)